MedPath

Comparison of the safety and effectiveness of local spray stem cells conditioned medium and erbium laser compared to triamcinolone and erbium laser in the treatment of hand eczema

Phase 1
Conditions
hand eczema.
L20.8
Diseases of the skin and subcutaneous tissue
Registration Number
IRCT20200127046282N26
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Healthy patients with hand eczema who have not used any topical medication in the past 2 weeks or any systemic medication in the past month.

Exclusion Criteria

Pregnancy
Breastfeeding
Severe sensitivity to the study drug

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduce or improve hand eczema. Timepoint: before and two weeks after the end of the study. Method of measurement: Using Eczema Extent and Severity Scale (EASI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath